Printer Friendly

Pfizer Japan Surveys Doctors on Blood Pressure Control.

Tokyo, Japan, Nov 9, 2005 - (JCNN) - Pfizer Japan announced the results on November 8th of its latest online survey of medical professionals on blood pressure control. With the aid of ACNielsen Japan, the company surveyed 472 doctors aged 40 or older who are currently taking antihypertensives, from August 6 to September 5.

Of the respondents, 24.2% take Norvasc by Pfizer, followed by Blopress by Takeda Pharmaceutical (16.7%) and Diovan by Novartis Pharma (16.3%). When asked about the reason why they choose Norvasc, 82.5% mentioned that the agent can exert an effect when it is used as a sole regimen. Also, 62.3% cited its long-lasting effect, namely the agent remains effective for 24 hours with a single administration, and 42.1% relied on the acknowledged evidence.

Of the respondents, 46.0% said that antihypertensives meet their targets of blood pressure control, and the remaining 54.0% confessed that they do not meet the criteria. Still, of those who have failed in blood pressure control, 83.2% believe that they control their blood pressure to a certain extent.

Regarding measuring blood pressure, only 34.1% of the respondents said that they check their blood pressure more than once a day, while 22.9% once in two or three days and 21.8% once a week.

A calcium antagonist initially released in the UK in 1991, Norvasc has been available in Japan since 1993. Worldwide sales of Norvasc reached $4.46 billion in fiscal 2004.

Source: JCN

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Geographic Code:9JAPA
Date:Nov 10, 2005
Previous Article:Meidensha, Siemens Power Generation to Join Hands in Fuel Cell Business in Japan.
Next Article:Interwired Conducts Internet Attitude Survey on Beef.

Related Articles
Super Aspirin.
Pop a pill, bring back the thrill: a little aqua-blue tablet has recharged the sex lives of millions and bankrolled the world's top drug firm.
Pfizer Japan Surveys Japanese Men Age Over 30 on Health and Sex.
Omron Healthcare, Tohoku University Jointly Surveyed 10,000 People on Blood Pressure Measurement.
Nippon Boehringer Ingelheim, Pfizer Japan Jointly Survey Japanese People Older Than 40 on COPD.
Pfizer Japan Surveys Children's Drug-taking Behaviors.
Daiichi Sankyo Files New Drug Application for Amoldipine Beslyte, Olmesartan Medoxomil Combination for Hypertension Treatment.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters